P Greenwald

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, Maryland 20892 7309, USA
    BMJ 324:714-8. 2002
  2. ncbi request reprint Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia
    James R Marshall
    Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Cancer Epidemiol Biomarkers Prev 15:1479-84. 2006
  3. ncbi request reprint A favorable view: progress in cancer prevention and screening
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 174:3-17. 2007
  4. ncbi request reprint Lifestyle and medical approaches to cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 166:1-15. 2005
  5. ncbi request reprint Clinical trials in cancer prevention: current results and perspectives for the future
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Nutr 134:3507S-3512S. 2004
  6. ncbi request reprint The future of cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Room 2040, 31 Center Dr, MSC 2580, Bethesda, MD 20892 7309, USA
    Semin Oncol Nurs 21:296-8. 2005
  7. ncbi request reprint Preface. The applications of bioinformatics in cancer detection
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Betheda, MD 20892 7309, USA
    Ann N Y Acad Sci 1020:ix-x. 2004
  8. ncbi request reprint An evidence-based approach to cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Eur J Cancer Prev 11:S43-7. 2002
  9. ncbi request reprint Clinical trials of vitamin and mineral supplements for cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Am J Clin Nutr 85:314S-317S. 2007
  10. ncbi request reprint Cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    J Clin Oncol 20:14S-22S. 2002

Detail Information

Publications28

  1. pmc Cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, Maryland 20892 7309, USA
    BMJ 324:714-8. 2002
  2. ncbi request reprint Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia
    James R Marshall
    Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Cancer Epidemiol Biomarkers Prev 15:1479-84. 2006
    ..Subject accrual is expected to be completed by the fall of 2006, with trial completion in 2009...
  3. ncbi request reprint A favorable view: progress in cancer prevention and screening
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 174:3-17. 2007
    ..If these biomarkers can be validated, they might help to reduce cancer mortality...
  4. ncbi request reprint Lifestyle and medical approaches to cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Recent Results Cancer Res 166:1-15. 2005
    ....
  5. ncbi request reprint Clinical trials in cancer prevention: current results and perspectives for the future
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Nutr 134:3507S-3512S. 2004
    ....
  6. ncbi request reprint The future of cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Room 2040, 31 Center Dr, MSC 2580, Bethesda, MD 20892 7309, USA
    Semin Oncol Nurs 21:296-8. 2005
    ..To hypothesize on the future of cancer prevention based on past and current progress of the field, as well as possible assimilation of knowledge in other fields that may be applied to cancer prevention...
  7. ncbi request reprint Preface. The applications of bioinformatics in cancer detection
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Betheda, MD 20892 7309, USA
    Ann N Y Acad Sci 1020:ix-x. 2004
  8. ncbi request reprint An evidence-based approach to cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Suite 2040, Bethesda, MD 20892 7309, USA
    Eur J Cancer Prev 11:S43-7. 2002
    ..Development of valid surrogate end point biomarkers for clinical disease that can be modulated by interventions is essential to accelerate progress in cancer prevention clinical trials...
  9. ncbi request reprint Clinical trials of vitamin and mineral supplements for cancer prevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Am J Clin Nutr 85:314S-317S. 2007
    ....
  10. ncbi request reprint Cancer prevention clinical trials
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    J Clin Oncol 20:14S-22S. 2002
    ..In addition, two lifestyle factors that have potential to influence cancer risk-obesity and functionally enhanced foods-are discussed in the context of their link between clinical and public health-related research...
  11. ncbi request reprint From carcinogenesis to clinical interventions for cancer prevention
    P Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Suite 2040, Bethesda, MD 20892 7309, USA
    Toxicology 166:37-45. 2001
    ..The development of valid intermediate biomarkers that can serve as surrogate endpoints for clinical disease is urgently needed to accelerate advances in clinical trials for cancer prevention...
  12. ncbi request reprint Diet and cancer prevention
    P Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Building 31, Room 10A52, 31 Center Drive, MSC 2580, Bethesda, MD 20892 2580, USA
    Eur J Cancer 37:948-65. 2001
    ..Such basic research is fundamental to cancer prevention strategies that incorporate effective dietary interventions for target populations...
  13. ncbi request reprint Creating a new paradigm in nutrition research within the National Cancer Institute
    P Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Nutr 130:3103-5. 2000
    ....
  14. ncbi request reprint Molecular targets for nutrients involved with cancer prevention
    J A Milner
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA
    Nutr Cancer 41:1-16. 2001
    ..Undeniably, embracing new genomic technologies offers exciting opportunities for advances in the broad area of nutrition, especially those related to cancer prevention...
  15. ncbi request reprint Cancer risk factors for selecting cohorts for large-scale chemoprevention trials
    P Greenwald
    Division of Cancer Prevention and Control, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Cell Biochem Suppl 25:29-36. 1996
    ..The validation of biomarkers as surrogate endpoints for cancer incidence in high-risk cohorts will allow more agents to be evaluated in shorter studies that use fewer subjects to achieve the desired statistical power...
  16. ncbi request reprint Cancer chemoprevention: progress and promise
    G J Kelloff
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
    Eur J Cancer 35:2031-8. 1999
    ..The large number of chemoprevention research programmes now ongoing ensures that the promise of chemoprevention will continue to be realised in the next decade...
  17. ncbi request reprint Overview of U.S. National Cancer Institute (USNCI) chemoprevention research
    K A Johnson
    Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland 29892
    Acta Oncol 33:5-11. 1994
    ..Resources required for large-scale trials compel greater attention to efficient trial design, concept development and review, priority setting, management, budgeting, and collaboration...
  18. pmc Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
    I U Ali
    Division for Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892, USA
    Br J Cancer 93:953-9. 2005
    ..Our analysis underscores the significance of the overall allelic architecture of Cox-2 as an important determinant for risk assessment...
  19. ncbi request reprint Cancer risk and diet in India
    R Sinha
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892 7273, USA
    J Postgrad Med 49:222-8. 2003
    ..From a public health perspective, there is an increasing need to develop cancer prevention programs responsive to the unique diets and cultural practices of the people of India...
  20. ncbi request reprint Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers
    Iqbal Unnisa Ali
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Oncol Rep 15:1367-72. 2006
    ..Validation of these biomarkers would have significant implications for the early detection of lung cancer and better management of high-risk patients...
  21. ncbi request reprint Nutritional interventions in cancer prevention
    Philip R Taylor
    National Cancer Institute, 6116 Executive Blvd, Rm 705, Bethesda, MD 20892 8314, USA
    J Clin Oncol 23:333-45. 2005
    ....
  22. ncbi request reprint Nutrition and physical activity and chronic disease prevention: research strategies and recommendations
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 A410, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 96:1276-87. 2004
    ....
  23. ncbi request reprint Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
    Zhen Xiao
    Laboratory of Proteomics and Analytical Technologies and Advanced Biomedical Computing Center, SAIC Frederick Inc, National Cancer Institute at Frederick, Frederick, Maryland, USA
    Cancer Res 64:2904-9. 2004
    ..In particular, a spectral feature at m/z 16,961.4 was identified as a strong discriminator between response and nonresponse to celecoxib at the highest dose...
  24. ncbi request reprint The antioxidant conundrum in cancer
    Harold E Seifried
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Boulevard, Suite 3160, Bethesda, MD 20852, USA
    Cancer Res 63:4295-8. 2003
    ..Overall, current knowledge makes it premature to generalize and make specific recommendations about antioxidant usage for those at high risk for cancer or undergoing treatment...
  25. ncbi request reprint Micronutrients in cancer chemoprevention
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7309, USA
    Cancer Metastasis Rev 21:217-30. 2002
    ..Research priorities include investigation of possible molecular targets for micronutrients and whether genetic and epigenetic events dictate direction and magnitude of the response...
  26. ncbi request reprint Beta-carotene and lung cancer: a lesson for future chemoprevention investigations?
    Peter Greenwald
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:E1. 2003
  27. ncbi request reprint Toward improved implementation of evidence-based clinical algorithms: clinical practice guidelines, clinical decision rules, and clinical pathways
    Gary M Gaddis
    St Luke s Hospital of Kansas City and University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Acad Emerg Med 14:1015-22. 2007
    ....
  28. ncbi request reprint A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine
    Benjamin W Friedman
    Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY 10467, USA
    Ann Emerg Med 52:399-406. 2008
    ..We compare prochlorperazine 10 mg intravenously versus metoclopramide 20 mg intravenously for the emergency department (ED) treatment of acute migraine...